Loading company…
Novavita Thera develops liver cell and gene therapies for liver and metabolic diseases.
Founded in 2019 and based in Minnesota, US, Novavita Thera, formerly Cytotheryx, is developing therapies for liver and metabolic diseases. Its work includes a bioincubator for primary human hepatocytes to support disease research and development of drug delivery, cell and gene therapies, liver assist devices and allotransplantation. In January 2026, it raised USD 60 million in Series A funding from Ouroboros Group through Ouroboros Family Founders Fund I, LP.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in